B. Porter

发表

A phase I / II trial of iodine-131 – tositumomab ( anti-CD 20 ) , etoposide , cyclophosphamide , and autologous stem cell transplantation for relapsed B-cell lymphomas

S. A. Bush, I. Bernstein, J. Eary, 2000 .

Imaging and treatment of B-cell lymphoma.

I. Bernstein, J. Eary, W. Nelp, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.

I. Bernstein, J. Eary, W. Nelp, 1993, The New England journal of medicine.

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

I. Bernstein, J. Eary, W. Nelp, 1995, The Lancet.

A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.

S. A. Bush, I. Bernstein, J. Eary, 2000, Blood.

The thymus is typically small at 1 year after autologous or allogeneic T-cell-replete hematopoietic cell transplantation into adults

D. Maloney, J. Storek, B. Porter, 2004, Bone Marrow Transplantation.

High Dose Radiolabeled Antibody Therapy of Lymphoma 1

I. Bernstein, J. Eary, W. Nelp, 2006 .

High-dose radioimmunotherapy of B cell lymphomas.

J. Eary, W. Nelp, K. Krohn, 1990, Frontiers of radiation therapy and oncology.

Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.

D. Berry, L. Esserman, D. Kontos, 2021, Radiology.

High dose radiolabeled antibody therapy of lymphoma.

I. Bernstein, J. Eary, W. Nelp, 1990, Cancer Research.

High-Dose Radioimmunotherapy of B Cell Lymphomas1

I. Bernstein, J. Eary, W. Nelp, 1989 .